Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierantonio Menna

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Pharmacological Reviews|June 1, 2004
Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicityGiorgio Minotti, Pierantonio Menna, Emanuela Salvatorelli, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 10, 2020
Predictors of Early or Delayed Diastolic Dysfunction After Anthracycline-Based or Nonanthracycline Chemotherapy: A Pharmacological AppraisalGiorgio Minotti, Pierantonio Menna, Massimiliano Camilli, et al.
Progress in Cardiovascular Diseases|July 18, 2024
Anthracyclines, Diastolic Dysfunction and the road to Heart Failure in Cancer survivors: An untold storyMassimiliano Camilli, Péter Ferdinandy, Emanuela Salvatorelli, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 16, 2009
Doxorubicinolone formation and efflux: a salvage pathway against epirubicin accumulation in human heartEmanuela Salvatorelli, Pierantonio Menna, Mario Lusini, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 2017
Modeling Human Myocardium Exposure to Doxorubicin Defines the Risk of Heart Failure from Low-Dose DoxorubicinEmanuela Salvatorelli, Pierantonio Menna, Massimo Chello, et al.
Chemotherapy|August 24, 2020
Further Analytical, Pharmacokinetic, and Clinical Observations on Low-Dose Ponatinib in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaPierantonio Menna, Ugo De Grazia, Francesco Marchesi, et al.
Methods in Enzymology|March 25, 2004
Doxorubicin cardiotoxicity and the control of iron metabolism: quinone-dependent and independent mechanismsGiorgio Minotti, Stefania Recalcati, Pierantonio Menna, et al.
British Journal of Haematology|August 2, 2019
Efficacy and safety of low dose ponatinib in a case of Ph-positive acute lymphoblastic leukaemiaFrancesco Marchesi, Emanuela Salvatorelli, Daniela Renzi, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 13, 2026
Optimizing Treatment, Minimizing Risk: Therapeutic Drug Monitoring in Hematological MalignanciesJon Salmanton-García, Francesco Marchesi, Oliver A Cornely, et al.
Molecular Interventions|May 5, 2011
Matters of the heart: the case of TNFalpha-targeting drugsFabio Cacciapaglia, Pierantonio Menna, Luca Navarini, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Pharmacological Reviews|June 1, 2004
Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicityGiorgio Minotti, Pierantonio Menna, Emanuela Salvatorelli, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 10, 2020
Predictors of Early or Delayed Diastolic Dysfunction After Anthracycline-Based or Nonanthracycline Chemotherapy: A Pharmacological AppraisalGiorgio Minotti, Pierantonio Menna, Massimiliano Camilli, et al.
Progress in Cardiovascular Diseases|July 18, 2024
Anthracyclines, Diastolic Dysfunction and the road to Heart Failure in Cancer survivors: An untold storyMassimiliano Camilli, Péter Ferdinandy, Emanuela Salvatorelli, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 16, 2009
Doxorubicinolone formation and efflux: a salvage pathway against epirubicin accumulation in human heartEmanuela Salvatorelli, Pierantonio Menna, Mario Lusini, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 2017
Modeling Human Myocardium Exposure to Doxorubicin Defines the Risk of Heart Failure from Low-Dose DoxorubicinEmanuela Salvatorelli, Pierantonio Menna, Massimo Chello, et al.
Chemotherapy|August 24, 2020
Further Analytical, Pharmacokinetic, and Clinical Observations on Low-Dose Ponatinib in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaPierantonio Menna, Ugo De Grazia, Francesco Marchesi, et al.
Methods in Enzymology|March 25, 2004
Doxorubicin cardiotoxicity and the control of iron metabolism: quinone-dependent and independent mechanismsGiorgio Minotti, Stefania Recalcati, Pierantonio Menna, et al.
British Journal of Haematology|August 2, 2019
Efficacy and safety of low dose ponatinib in a case of Ph-positive acute lymphoblastic leukaemiaFrancesco Marchesi, Emanuela Salvatorelli, Daniela Renzi, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 13, 2026
Optimizing Treatment, Minimizing Risk: Therapeutic Drug Monitoring in Hematological MalignanciesJon Salmanton-García, Francesco Marchesi, Oliver A Cornely, et al.
Molecular Interventions|May 5, 2011
Matters of the heart: the case of TNFalpha-targeting drugsFabio Cacciapaglia, Pierantonio Menna, Luca Navarini, et al.
Pageof 7